CTSN PRIMARY Trial (Mitral Valve Regurgitation) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to compare treatment options for mitral valve regurgitation.
Mitral Valve Regurgitation (MR)
Who Can Participate in the Study?
Adults with mitral valve regurgitation who plan to have it repaired.
For more information about who can join this study, contact the study team at shelly.fincannon@duke.edu.
What is Involved?
If you choose to join this study, you will:
- Get a random assignment (like a coin flip) to 1 of 2 groups
-- Group 1: you will have mitral valve surgery, performed in an operating room by a cardiac surgeon
-- Group 2: you will have transcatheter edge-to-edge repair, performed in a cardiac catheterization laboratory by an interventional cardiologist
Participants assigned to both groups will also:
- Have echocardiograms
- Complete a six-minute walk test
- Answer questionnaires
If you do not want to be part of the study that randomly assigns you to treatment, you can participate in a registry. If you join the registry, we will collect data from your medical records related to your treatment for MR so we can learn more about the condition and its treatment outcomes.
Study Details
